Secondary goals include evaluating the combined impact on inhibiting cancer cell growth, measuring insulin/PI3K pathway activation, assessing changes in weight and body composition, and determining the efficacy of inducing a ketogenic state in synergy with endocrine therapy. Here, PIK3CB is linked to cancer.